TAMOLTRA Film coated tablet Ref.[115184] Active ingredients: Paracetamol Tramadol

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2025  Publisher: Pharma Dynamics (Pty) Ltd, 1<sup>st</sup> Floor Grapevine House, Steenberg Office Park, Silverwood Close, Westlake, Cape Town, 7945, South Africa, Tel: 0860-PHARMA (742 762) / +2721 707 7000

Product name and form

TAMOLTRA (37,5 mg/325 mg) film coated tablet.

TAMOLTRA FORTE (75 mg/650 mg) film coated tablet.

Pharmaceutical Form

Film coated tablet.

TAMOLTRA: Slightly yellow-brown, oval, convex film coated tablets.

TAMOLTRA FORTE: Slightly orange, oval, biconvex film coated tablets widely scored on both sides.

Qualitative and quantitative composition

TAMOLTRA: Each film coated tablet contains tramadol hydrochloride 37,5 mg and paracetamol 325 mg.

TAMOLTRA FORTE: Each film coated tablet contains tramadol hydrochloride 75 mg and paracetamol 650 mg.

Sugar free.

For the full list of excipients, see section 6.1.

Active Ingredient

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.

Tramadol is a centrally acting opioid analgesic. It is a non selective pure agonist at μ-, δ- and κ-opioid receptors with a higher affinity for the μ-receptor. Other mechanisms which may contribute to its analgesic effect are inhibition of neuronal reuptake of noradrenaline and enhancement of serotonin release. Tramadol has an antitussive effect. In contrast to morphine, analgesic doses of tramadol over a wide range have no respiratory depressant effect.

List of Excipients

Tablet core:

Magnesium stearate
Microcrystalline cellulose
Pregelatinised starch
Sodium starch glycolate (Type A)

TAMOLTRA Film coating:

Opadry Yellow 15B82958 composition:

Hypromellose
Polyethylene glycol 400
Polysorbate 80
Titanium dioxide (C.I. 77891)
Yellow iron oxide (C.I. 77492)

TAMOLTRA FORTE Film coating:

Red iron oxide, E172

Opadry Yellow 15B82958 composition:

Hypromellose
Macrogol 400 (polyethylene glycol)
Polysorbate 80
Titanium dioxide
Yellow iron oxide

Pack sizes and marketing

TAMOLTRA is available in blister packs consisting of PVC/PVDC, white film and aluminium foil, with 20, 30 or 60 tablets packed in an outer carton.

TAMOLTRA FORTE is available in blister packs consisting of PVC/PVDC, white film and aluminium foil, with 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 tablets packed in an outer carton.

Not all pack sizes may be marketed.

Marketing authorization holder

Pharma Dynamics (Pty) Ltd, 1st Floor Grapevine House, Steenberg Office Park, Silverwood Close, Westlake, Cape Town, 7945, South Africa, Tel: 0860-PHARMA (742 762) / +2721 707 7000

Marketing authorization dates and numbers

TAMOLTRA: A46/2.9/0976
TAMOLTRA FORTE: A47/2.9/0926

TAMOLTRA: 27 July 2017
TAMOLTRA FORTE: 03 May 2022

Drugs

Drug Countries
TAMOLTRA South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.